Niva Bupa Health Insurance Company IPO GMP History
Niva Bupa Health Insurance Company IPO has been listed on November 14, 2024 at a listing price of ₹78.14, against the issue price of ₹74 — a gain of ₹4.14 (+5.59%). The GMP peaked at ₹3 on 10 November 2024 and reached a low of ₹0 on 11 November 2024. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Niva Bupa Health Insurance Company IPO raised ₹2200 Cr. through its IPO at a price band of ₹70 to ₹74 per share, with a lot size of 200 shares. The IPO was open for subscription from 07 Nov 2024 to 11 Nov 2024.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 11:30 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 13 Nov 2024 | ₹ 1 | ▲ | 1% | — | — |
| 11 Nov 2024 | ₹ 0 | ▼ | -- | — | — |
| 10 Nov 2024 | ₹ 3 | — | 4% | — | — |
Niva Bupa Health Insurance Company IPO dates
Key dates from opening to listing. Today is 11 November.
- Open 07 Nov 2024
- Close 11 Nov 2024
- Allotment 12 Nov 2024
- Refund/credit 13 Nov 2024
- Listing 14 Nov 2024
Niva Bupa Health Insurance Company IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹74 |
|---|---|
| GMP-based estimate (pre-listing) | ₹75 (+1.4%) |
| Listing gain / loss | +₹4.14 per share |
| Listing date | 14 Nov, 2024 |
| Actual listing price | ₹78.14 (+5.59%) |
Is Niva Bupa Health Insurance Company IPO GMP reliable?
Grey market premium for Niva Bupa Health Insurance Company IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Niva Bupa Health Insurance Company IPO full review for a fundamentals-based assessment before making any grey market trades.
Niva Bupa Health Insurance Company IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Niva Bupa Health Insurance Company IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Niva Bupa Health Insurance Company IPO
Niva Bupa Health Insurance Company Limited was incorporated in September 2008 as a joint venture between Max India and Bupa Singapore Holdings. It is a standalone health insurer focused on the retail health market.
As per Redseer, it is one of India's largest and fastest growing standalone health insurers, with overall health gross direct premium income of Rs 54,944.28 million in Fiscal 2024. Its health GDPI grew 41.37% a year from Fiscal 2022 to 2024.
Its promoters are Bupa Singapore Holdings, Fettle Tone LLP and Bupa Investments Overseas.
The IPO was Rs 2,200 crore, with Rs 800.00 crore of fresh issue and Rs 1,400.00 crore of offer for sale by Bupa Singapore Holdings and Fettle Tone LLP. The fresh money was meant to strengthen the capital base and solvency.
Frequently asked
What is the GMP of Niva Bupa Health Insurance Company IPO?
The current Grey Market Premium (GMP) of Niva Bupa Health Insurance Company IPO is ₹ 1.
What is the Kostak Price of Niva Bupa Health Insurance Company IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Niva Bupa Health Insurance Company IPO is not available.
What is the Subject to Sauda Price of Niva Bupa Health Insurance Company IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Niva Bupa Health Insurance Company IPO?
Niva Bupa Health Insurance Company IPO listed on November 14, 2024 at ₹78.14, against the issue price of ₹74 — a gain of +5.59%.
How did the GMP of Niva Bupa Health Insurance Company IPO trend before listing?
The GMP of Niva Bupa Health Insurance Company IPO was rising in its final days before listing. The GMP peaked at ₹3 on 10 November 2024. View the day-wise table above for the complete GMP history.
Explore Niva Bupa Health Insurance Company IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
